Letter to the editor

给编辑的信
  • 文章类型: Journal Article
    这封信涉及Lv等人发表在《世界实验医学杂志》上的题为“红细胞分布宽度:高甘油三酯血症诱导的急性胰腺炎严重程度的预测因子”的研究。该研究提供了对红细胞分布宽度(RDW)作为高甘油三酯血症诱导的急性胰腺炎患者持续器官衰竭的预测指标的有价值的分析。研究结果表明,RDW,结合急性胰腺炎严重程度的床旁指数评分,可以提高严重结局的预测准确性。建议进一步研究RDW在不同严重程度的急性胰腺炎中的作用。此外,强调需要大规模和多中心的前瞻性研究来验证这些发现.
    This letter addresses the study titled \"Red cell distribution width: A predictor of the severity of hypertriglyceridemia-induced acute pancreatitis\" by Lv et al published in the World Journal of Experimental Medicine. The study offers a valuable analysis of red cell distribution width (RDW) as a predictive marker for persistent organ failure in patients with hypertriglyceridemia-induced acute pancreatitis. The study results suggest that RDW, combined with the Bedside Index for Severity in Acute Pancreatitis score, could enhance the predictive accuracy for severe outcomes. Further investigation into the role of RDW in different severities of acute pancreatitis is recommended. Additionally, the need for large-scale and multicenter prospective studies to validate these findings is emphasized.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这封信给编辑的标题为“NLR的预测值,Fib4和APRI在肝细胞癌患者肝切除术后肝衰竭发生中的作用\"由Kuang等人发表在《世界胃肠外科杂志》上。该研究承认了全面的患者数据分析,同时表明需要进一步讨论这些标志物在不同患者人群中的临床适用性。这封信建议前瞻性研究进行验证,并考虑混杂因素的影响。这一发现强调了这项研究在改善肝细胞癌管理方面的重要性。
    This letter to the editor addresses the study titled \"Predictive value of NLR, Fib4, and APRI in the occurrence of liver failure after hepatectomy in patients with hepatocellular carcinoma\" by Kuang et al in the World Journal of Gastrointestinal Surgery. The study acknowledges the comprehensive patient data analysis while suggesting that there is a need for further discussion on the clinical applicability of these markers across diverse patient populations. This letter recommends prospective studies for validation and considers the influence of confounding factors. This finding underscores the significance of this study in improving hepatocellular carcinoma management.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    非酒精性脂肪性肝病(NAFLD)和代谢功能障碍相关的脂肪性肝病的诊断仅基于实验室参数评分,如肝脏脂肪变性指数,包括肝酶,性别,基础代谢指标,糖尿病的存在不足以排除肝酶紊乱的其他原因,特别是药物和自身免疫性相关的肝脏疾病。正如指南建议的那样,超声是NAFLD成像的首选一线诊断程序,因为它提供了额外的诊断信息,并且生物标志物/评分和瞬时弹性成像的组合可能会赋予额外的诊断准确性,并且从以前的类似研究中也很明显.
    The diagnosis of non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease only on the basis of laboratory parameter score such as Hepatic Steatosis Index which includes liver enzymes, gender, basal metabolic index, and presence of diabetic mellitus is not sufficient to exclude other causes of deranged liver enzymes especially medications and autoimmune related liver diseases. As the guideline suggests ultrasound is the preferred first-line diagnostic procedure for imaging of NAFLD, as it provides additional diagnostic information and the combination of biomarkers/scores and transient elastography might confer additional diagnostic accuracy and evident from previous similar studies too.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    如何以及为什么在给编辑的当代政治信件中使用叙述进行论证?为了找到这个问题的答案,我检查了瑞士和德国日报给编辑的大约50封信,所有这些都与COVID-19有关。在所有的信件中,作者通过讲故事来提出论点。事实证明,这个故事通常是在具有评价性的论证中从示例中论证的前提。对于作家来说,展开这样的前提作为叙事具有这样的优点,即它们可以与示例性事件一起连续传达评估。这种叙事论证的社会文化利益可能在于,它们可以在政治辩论中轻松地将社会微观层面与社会宏观层面联系起来。
    How and why are narratives used for argumentation in contemporary political letters to the editor? In order to find answers to this question, I examine about 50 letters to the editor from Swiss and German daily newspapers, all of which are related to COVID-19. In all letters, the writer presents an argument by telling a story. It turns out that the story usually serves as a premise for an argument from example in an argumentation with an evaluative standpoint. For the writers, unfolding such a premise as a narrative has the advantage that they can successively convey an evaluation together with the exemplary event. A socio-cultural benefit of such narrative arguments from example might be that they can easily connect the social micro-level with the societal macro-level in political debates.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    给编辑的这封信与标题为“过去”的评论有关,present,以及乙型肝炎病毒长期治疗的未来。“慢性乙型肝炎(CHB)代表了一个重要而紧迫的公共卫生问题。及时识别和有效的抗病毒治疗有可能降低与乙型肝炎病毒(HBV)慢性感染相关的肝脏死亡率。然而,目前CHB的全球治疗率仍然明显较低,国家CHB指南提倡的过于严格的治疗标准是导致这些低费率的一个因素。然而,最近在理解这种疾病方面取得的进展和新型抗病毒药物的出现促使人们必须重新评估治疗标准,以扩大潜在受益者的范围。一个迫在眉睫的需要出现一个新的范式为CHB患者的分类,HBV感染者抗病毒治疗资格的扩大,甚至简化CHB的诊断过程,以扩大成本效益和增加生存前景。
    The present letter to the editor is related to the review with the title \"Past, present, and future of long-term treatment for hepatitis B virus.\" Chronic hepatitis B (CHB) represents an important and pressing public health concern. Timely identification and effective antiviral therapy hold the potential to reduce liver-related mortality attributable to chronic infection with hepatitis B virus (HBV) substantially. However, the current global treatment rates for CHB remain conspicuously low, with the excessively stringent treatment criteria advocated by national CHB guidelines being a contributing factor to these low rates. Nevertheless, recent strides in comprehending this malady and the emergence of novel antiviral agents prompt the imperative re-evaluation of treatment standards to extend the sphere of potential beneficiaries. An impending need arises for a novel paradigm for the classification of patients with CHB, the expansion of antiviral treatment eligibility for HBV-infected individuals, and even the streamlining of the diagnostic process for CHB to amplify cost-effectiveness and augment survival prospects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Review
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    以下给编辑的信强调了标题为“炎症性肠病相关的结直肠癌:过去,现在和未来的观点“,世界J胃肠病研究所2022年3月15日;14(3):547-567。有必要探讨炎症在促进胃肠道肿瘤发生发展中的作用。
    The following letter to the editor highlights the review titled \"Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives\" in World J Gastrointest Oncol 2022 March 15; 14(3): 547-567. It is necessary to explore the role of inflammation in promoting tumorigenesis and development of gastrointestinal cancers.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    期刊对信件施加相当大的控制,批评先前研究的评论和在线评论(出版后批评)。我们在22个科学学科(N=330种期刊)中的15种排名最高的期刊上评估了与出版后评论相关的政策(研究一)和实践(研究二)。两百零七种(63%)期刊接受了发表后的批评,并经常对长度(中位数1000,四分位数范围(IQR)500-1200字)和提交时间(中位数12,IQR4-26周)施加限制。最严格的限制是175字和两周;一些政策没有限制。在2018年接受发表后批评的期刊发表的2066篇随机抽样研究文章中,39(1.9%,95%置信区间[1.4,2.6])与至少一个出版后批评相关联(总共有58个出版后批评)。在58个出版后的批评中,44收到了提交人的答复,其中41人断言最初的结论没有改变。临床医学具有最活跃的出版后批评文化:所有期刊都接受出版后批评,并且总体上发表了最多的出版后批评。但也对长度(中位数400,IQR400-550字)和提交时间(中位数4,IQR4-6周)施加了最严格的限制.我们的研究结果表明,排名靠前的学术期刊往往对培养构成严重障碍,出版后批评的文献和传播。
    Journals exert considerable control over letters, commentaries and online comments that criticize prior research (post-publication critique). We assessed policies (Study One) and practice (Study Two) related to post-publication critique at 15 top-ranked journals in each of 22 scientific disciplines (N = 330 journals). Two-hundred and seven (63%) journals accepted post-publication critique and often imposed limits on length (median 1000, interquartile range (IQR) 500-1200 words) and time-to-submit (median 12, IQR 4-26 weeks). The most restrictive limits were 175 words and two weeks; some policies imposed no limits. Of 2066 randomly sampled research articles published in 2018 by journals accepting post-publication critique, 39 (1.9%, 95% confidence interval [1.4, 2.6]) were linked to at least one post-publication critique (there were 58 post-publication critiques in total). Of the 58 post-publication critiques, 44 received an author reply, of which 41 asserted that original conclusions were unchanged. Clinical Medicine had the most active culture of post-publication critique: all journals accepted post-publication critique and published the most post-publication critique overall, but also imposed the strictest limits on length (median 400, IQR 400-550 words) and time-to-submit (median 4, IQR 4-6 weeks). Our findings suggest that top-ranked academic journals often pose serious barriers to the cultivation, documentation and dissemination of post-publication critique.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号